カテゴリー： Market Monitor Global, 世界, 医療/バイオ

下垂体ACTH過剰分泌薬の世界市場見通し2023年-2029年

◆英語タイトル：Pituitary ACTH Hypersecretion Drug Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8558 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：72 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Pituitary ACTH Hypersecretion Drug Market 調査レポートは次の情報を含め、グローバルにおけるの下垂体ACTH過剰分泌薬市場規模と予測を収録しています。・世界の下垂体ACTH過剰分泌薬市場：売上、2018年-2023年、2024年-2029年
・世界の下垂体ACTH過剰分泌薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の下垂体ACTH過剰分泌薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「AT-814」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

下垂体ACTH過剰分泌薬のグローバル主要企業は、Alder Biopharmaceuticals Inc.、 Corcept Therapeutics Incorporated、 Cortendo AB、 Cyclacel Pharmaceuticals, Inc.、 ElexoPharm GmbH、 Ipsen S.A.、 Isis Pharmaceuticals, Inc.、 Novartis AG、 Orphagen Pharmaceuticals, Inc.、 Pfizer Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、下垂体ACTH過剰分泌薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の下垂体ACTH過剰分泌薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の下垂体ACTH過剰分泌薬市場：タイプ別市場シェア、2022年
・AT-814、ATR-101、BIM-23A758、COR-005、CORT-125134、ISIS-GCCRRx、その他

世界の下垂体ACTH過剰分泌薬市場：用途別、2018年-2023年、2024年-2029年
世界の下垂体ACTH過剰分泌薬市場：用途別市場シェア、2022年
・診療所、病院、その他

世界の下垂体ACTH過剰分泌薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の下垂体ACTH過剰分泌薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における下垂体ACTH過剰分泌薬のグローバル売上、2018年-2023年
・主要企業における下垂体ACTH過剰分泌薬のグローバル売上シェア、2022年
・主要企業における下垂体ACTH過剰分泌薬のグローバル販売量、2018年-2023年
・主要企業における下垂体ACTH過剰分泌薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Alder Biopharmaceuticals Inc.、 Corcept Therapeutics Incorporated、 Cortendo AB、 Cyclacel Pharmaceuticals, Inc.、 ElexoPharm GmbH、 Ipsen S.A.、 Isis Pharmaceuticals, Inc.、 Novartis AG、 Orphagen Pharmaceuticals, Inc.、 Pfizer Inc.

*************************************************************

・調査・分析レポートの概要
下垂体ACTH過剰分泌薬市場の定義
市場セグメント
世界の下垂体ACTH過剰分泌薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の下垂体ACTH過剰分泌薬市場規模
世界の下垂体ACTH過剰分泌薬市場規模：2022年 VS 2029年
世界の下垂体ACTH過剰分泌薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの下垂体ACTH過剰分泌薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の下垂体ACTH過剰分泌薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：AT-814、ATR-101、BIM-23A758、COR-005、CORT-125134、ISIS-GCCRRx、その他
下垂体ACTH過剰分泌薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：診療所、病院、その他
下垂体ACTH過剰分泌薬の用途別グローバル売上・予測

・地域別市場分析
地域別下垂体ACTH過剰分泌薬市場規模 2022年と2029年
地域別下垂体ACTH過剰分泌薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Alder Biopharmaceuticals Inc.、 Corcept Therapeutics Incorporated、 Cortendo AB、 Cyclacel Pharmaceuticals, Inc.、 ElexoPharm GmbH、 Ipsen S.A.、 Isis Pharmaceuticals, Inc.、 Novartis AG、 Orphagen Pharmaceuticals, Inc.、 Pfizer Inc.
...

This report aims to provide a comprehensive presentation of the global market for Pituitary ACTH Hypersecretion Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pituitary ACTH Hypersecretion Drug. This report contains market size and forecasts of Pituitary ACTH Hypersecretion Drug in global, including the following market information:
Global Pituitary ACTH Hypersecretion Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pituitary ACTH Hypersecretion Drug Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Pituitary ACTH Hypersecretion Drug companies in 2022 (%)
The global Pituitary ACTH Hypersecretion Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
AT-814 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pituitary ACTH Hypersecretion Drug include Alder Biopharmaceuticals Inc., Corcept Therapeutics Incorporated, Cortendo AB, Cyclacel Pharmaceuticals, Inc., ElexoPharm GmbH, Ipsen S.A., Isis Pharmaceuticals, Inc., Novartis AG and Orphagen Pharmaceuticals, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pituitary ACTH Hypersecretion Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pituitary ACTH Hypersecretion Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Pituitary ACTH Hypersecretion Drug Market Segment Percentages, by Type, 2022 (%)
AT-814
ATR-101
BIM-23A758
COR-005
CORT-125134
ISIS-GCCRRx
Others
Global Pituitary ACTH Hypersecretion Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Pituitary ACTH Hypersecretion Drug Market Segment Percentages, by Application, 2022 (%)
Clinic
Hospital
Others
Global Pituitary ACTH Hypersecretion Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Pituitary ACTH Hypersecretion Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pituitary ACTH Hypersecretion Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pituitary ACTH Hypersecretion Drug revenues share in global market, 2022 (%)
Key companies Pituitary ACTH Hypersecretion Drug sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Pituitary ACTH Hypersecretion Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alder Biopharmaceuticals Inc.
Corcept Therapeutics Incorporated
Cortendo AB
Cyclacel Pharmaceuticals, Inc.
ElexoPharm GmbH
Ipsen S.A.
Isis Pharmaceuticals, Inc.
Novartis AG
Orphagen Pharmaceuticals, Inc.
Pfizer Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pituitary ACTH Hypersecretion Drug, market overview.
Chapter 2: Global Pituitary ACTH Hypersecretion Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Pituitary ACTH Hypersecretion Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pituitary ACTH Hypersecretion Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pituitary ACTH Hypersecretion Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Pituitary ACTH Hypersecretion Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pituitary ACTH Hypersecretion Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pituitary ACTH Hypersecretion Drug Overall Market Size
2.1 Global Pituitary ACTH Hypersecretion Drug Market Size: 2022 VS 2029
2.2 Global Pituitary ACTH Hypersecretion Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pituitary ACTH Hypersecretion Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Pituitary ACTH Hypersecretion Drug Players in Global Market
3.2 Top Global Pituitary ACTH Hypersecretion Drug Companies Ranked by Revenue
3.3 Global Pituitary ACTH Hypersecretion Drug Revenue by Companies
3.4 Global Pituitary ACTH Hypersecretion Drug Sales by Companies
3.5 Global Pituitary ACTH Hypersecretion Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pituitary ACTH Hypersecretion Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pituitary ACTH Hypersecretion Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pituitary ACTH Hypersecretion Drug Players in Global Market
3.8.1 List of Global Tier 1 Pituitary ACTH Hypersecretion Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Pituitary ACTH Hypersecretion Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pituitary ACTH Hypersecretion Drug Market Size Markets, 2022 & 2029
4.1.2 AT-814
4.1.3 ATR-101
4.1.4 BIM-23A758
4.1.5 COR-005
4.1.6 CORT-125134
4.1.7 ISIS-GCCRRx
4.1.8 Others
4.2 By Type – Global Pituitary ACTH Hypersecretion Drug Revenue & Forecasts
4.2.1 By Type – Global Pituitary ACTH Hypersecretion Drug Revenue, 2018-2023
4.2.2 By Type – Global Pituitary ACTH Hypersecretion Drug Revenue, 2024-2029
4.2.3 By Type – Global Pituitary ACTH Hypersecretion Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Pituitary ACTH Hypersecretion Drug Sales & Forecasts
4.3.1 By Type – Global Pituitary ACTH Hypersecretion Drug Sales, 2018-2023
4.3.2 By Type – Global Pituitary ACTH Hypersecretion Drug Sales, 2024-2029
4.3.3 By Type – Global Pituitary ACTH Hypersecretion Drug Sales Market Share, 2018-2029
4.4 By Type – Global Pituitary ACTH Hypersecretion Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pituitary ACTH Hypersecretion Drug Market Size, 2022 & 2029
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application – Global Pituitary ACTH Hypersecretion Drug Revenue & Forecasts
5.2.1 By Application – Global Pituitary ACTH Hypersecretion Drug Revenue, 2018-2023
5.2.2 By Application – Global Pituitary ACTH Hypersecretion Drug Revenue, 2024-2029
5.2.3 By Application – Global Pituitary ACTH Hypersecretion Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Pituitary ACTH Hypersecretion Drug Sales & Forecasts
5.3.1 By Application – Global Pituitary ACTH Hypersecretion Drug Sales, 2018-2023
5.3.2 By Application – Global Pituitary ACTH Hypersecretion Drug Sales, 2024-2029
5.3.3 By Application – Global Pituitary ACTH Hypersecretion Drug Sales Market Share, 2018-2029
5.4 By Application – Global Pituitary ACTH Hypersecretion Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pituitary ACTH Hypersecretion Drug Market Size, 2022 & 2029
6.2 By Region – Global Pituitary ACTH Hypersecretion Drug Revenue & Forecasts
6.2.1 By Region – Global Pituitary ACTH Hypersecretion Drug Revenue, 2018-2023
6.2.2 By Region – Global Pituitary ACTH Hypersecretion Drug Revenue, 2024-2029
6.2.3 By Region – Global Pituitary ACTH Hypersecretion Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Pituitary ACTH Hypersecretion Drug Sales & Forecasts
6.3.1 By Region – Global Pituitary ACTH Hypersecretion Drug Sales, 2018-2023
6.3.2 By Region – Global Pituitary ACTH Hypersecretion Drug Sales, 2024-2029
6.3.3 By Region – Global Pituitary ACTH Hypersecretion Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pituitary ACTH Hypersecretion Drug Revenue, 2018-2029
6.4.2 By Country – North America Pituitary ACTH Hypersecretion Drug Sales, 2018-2029
6.4.3 US Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.4.4 Canada Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.4.5 Mexico Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pituitary ACTH Hypersecretion Drug Revenue, 2018-2029
6.5.2 By Country – Europe Pituitary ACTH Hypersecretion Drug Sales, 2018-2029
6.5.3 Germany Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.5.4 France Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.5.5 U.K. Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.5.6 Italy Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.5.7 Russia Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.5.8 Nordic Countries Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.5.9 Benelux Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pituitary ACTH Hypersecretion Drug Revenue, 2018-2029
6.6.2 By Region – Asia Pituitary ACTH Hypersecretion Drug Sales, 2018-2029
6.6.3 China Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.6.4 Japan Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.6.5 South Korea Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.6.6 Southeast Asia Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.6.7 India Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pituitary ACTH Hypersecretion Drug Revenue, 2018-2029
6.7.2 By Country – South America Pituitary ACTH Hypersecretion Drug Sales, 2018-2029
6.7.3 Brazil Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.7.4 Argentina Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pituitary ACTH Hypersecretion Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pituitary ACTH Hypersecretion Drug Sales, 2018-2029
6.8.3 Turkey Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.8.4 Israel Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
6.8.6 UAE Pituitary ACTH Hypersecretion Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Alder Biopharmaceuticals Inc.
7.1.1 Alder Biopharmaceuticals Inc. Company Summary
7.1.2 Alder Biopharmaceuticals Inc. Business Overview
7.1.3 Alder Biopharmaceuticals Inc. Pituitary ACTH Hypersecretion Drug Major Product Offerings
7.1.4 Alder Biopharmaceuticals Inc. Pituitary ACTH Hypersecretion Drug Sales and Revenue in Global (2018-2023)
7.1.5 Alder Biopharmaceuticals Inc. Key News & Latest Developments
7.2 Corcept Therapeutics Incorporated
7.2.1 Corcept Therapeutics Incorporated Company Summary
7.2.2 Corcept Therapeutics Incorporated Business Overview
7.2.3 Corcept Therapeutics Incorporated Pituitary ACTH Hypersecretion Drug Major Product Offerings
7.2.4 Corcept Therapeutics Incorporated Pituitary ACTH Hypersecretion Drug Sales and Revenue in Global (2018-2023)
7.2.5 Corcept Therapeutics Incorporated Key News & Latest Developments
7.3 Cortendo AB
7.3.1 Cortendo AB Company Summary
7.3.2 Cortendo AB Business Overview
7.3.3 Cortendo AB Pituitary ACTH Hypersecretion Drug Major Product Offerings
7.3.4 Cortendo AB Pituitary ACTH Hypersecretion Drug Sales and Revenue in Global (2018-2023)
7.3.5 Cortendo AB Key News & Latest Developments
7.4 Cyclacel Pharmaceuticals, Inc.
7.4.1 Cyclacel Pharmaceuticals, Inc. Company Summary
7.4.2 Cyclacel Pharmaceuticals, Inc. Business Overview
7.4.3 Cyclacel Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Major Product Offerings
7.4.4 Cyclacel Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Sales and Revenue in Global (2018-2023)
7.4.5 Cyclacel Pharmaceuticals, Inc. Key News & Latest Developments
7.5 ElexoPharm GmbH
7.5.1 ElexoPharm GmbH Company Summary
7.5.2 ElexoPharm GmbH Business Overview
7.5.3 ElexoPharm GmbH Pituitary ACTH Hypersecretion Drug Major Product Offerings
7.5.4 ElexoPharm GmbH Pituitary ACTH Hypersecretion Drug Sales and Revenue in Global (2018-2023)
7.5.5 ElexoPharm GmbH Key News & Latest Developments
7.6 Ipsen S.A.
7.6.1 Ipsen S.A. Company Summary
7.6.2 Ipsen S.A. Business Overview
7.6.3 Ipsen S.A. Pituitary ACTH Hypersecretion Drug Major Product Offerings
7.6.4 Ipsen S.A. Pituitary ACTH Hypersecretion Drug Sales and Revenue in Global (2018-2023)
7.6.5 Ipsen S.A. Key News & Latest Developments
7.7 Isis Pharmaceuticals, Inc.
7.7.1 Isis Pharmaceuticals, Inc. Company Summary
7.7.2 Isis Pharmaceuticals, Inc. Business Overview
7.7.3 Isis Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Major Product Offerings
7.7.4 Isis Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Sales and Revenue in Global (2018-2023)
7.7.5 Isis Pharmaceuticals, Inc. Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Pituitary ACTH Hypersecretion Drug Major Product Offerings
7.8.4 Novartis AG Pituitary ACTH Hypersecretion Drug Sales and Revenue in Global (2018-2023)
7.8.5 Novartis AG Key News & Latest Developments
7.9 Orphagen Pharmaceuticals, Inc.
7.9.1 Orphagen Pharmaceuticals, Inc. Company Summary
7.9.2 Orphagen Pharmaceuticals, Inc. Business Overview
7.9.3 Orphagen Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Major Product Offerings
7.9.4 Orphagen Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Sales and Revenue in Global (2018-2023)
7.9.5 Orphagen Pharmaceuticals, Inc. Key News & Latest Developments
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Company Summary
7.10.2 Pfizer Inc. Business Overview
7.10.3 Pfizer Inc. Pituitary ACTH Hypersecretion Drug Major Product Offerings
7.10.4 Pfizer Inc. Pituitary ACTH Hypersecretion Drug Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Inc. Key News & Latest Developments
8 Global Pituitary ACTH Hypersecretion Drug Production Capacity, Analysis
8.1 Global Pituitary ACTH Hypersecretion Drug Production Capacity, 2018-2029
8.2 Pituitary ACTH Hypersecretion Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Pituitary ACTH Hypersecretion Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pituitary ACTH Hypersecretion Drug Supply Chain Analysis
10.1 Pituitary ACTH Hypersecretion Drug Industry Value Chain
10.2 Pituitary ACTH Hypersecretion Drug Upstream Market
10.3 Pituitary ACTH Hypersecretion Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pituitary ACTH Hypersecretion Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Pituitary ACTH Hypersecretion Drug in Global Market
Table 2. Top Pituitary ACTH Hypersecretion Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Pituitary ACTH Hypersecretion Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Pituitary ACTH Hypersecretion Drug Revenue Share by Companies, 2018-2023
Table 5. Global Pituitary ACTH Hypersecretion Drug Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Pituitary ACTH Hypersecretion Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Pituitary ACTH Hypersecretion Drug Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Pituitary ACTH Hypersecretion Drug Product Type
Table 9. List of Global Tier 1 Pituitary ACTH Hypersecretion Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pituitary ACTH Hypersecretion Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Pituitary ACTH Hypersecretion Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Pituitary ACTH Hypersecretion Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs), 2018-2023
Table 15. By Type - Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs), 2024-2029
Table 16. By Application – Global Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Pituitary ACTH Hypersecretion Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Pituitary ACTH Hypersecretion Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs), 2018-2023
Table 20. By Application - Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs), 2024-2029
Table 21. By Region – Global Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Pituitary ACTH Hypersecretion Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Pituitary ACTH Hypersecretion Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs), 2018-2023
Table 25. By Region - Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs), 2024-2029
Table 26. By Country - North America Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Pituitary ACTH Hypersecretion Drug Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Pituitary ACTH Hypersecretion Drug Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Pituitary ACTH Hypersecretion Drug Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Pituitary ACTH Hypersecretion Drug Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Pituitary ACTH Hypersecretion Drug Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Pituitary ACTH Hypersecretion Drug Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Pituitary ACTH Hypersecretion Drug Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Pituitary ACTH Hypersecretion Drug Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Pituitary ACTH Hypersecretion Drug Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Pituitary ACTH Hypersecretion Drug Sales, (K Pcs), 2024-2029
Table 46. Alder Biopharmaceuticals Inc. Company Summary
Table 47. Alder Biopharmaceuticals Inc. Pituitary ACTH Hypersecretion Drug Product Offerings
Table 48. Alder Biopharmaceuticals Inc. Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Alder Biopharmaceuticals Inc. Key News & Latest Developments
Table 50. Corcept Therapeutics Incorporated Company Summary
Table 51. Corcept Therapeutics Incorporated Pituitary ACTH Hypersecretion Drug Product Offerings
Table 52. Corcept Therapeutics Incorporated Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Corcept Therapeutics Incorporated Key News & Latest Developments
Table 54. Cortendo AB Company Summary
Table 55. Cortendo AB Pituitary ACTH Hypersecretion Drug Product Offerings
Table 56. Cortendo AB Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Cortendo AB Key News & Latest Developments
Table 58. Cyclacel Pharmaceuticals, Inc. Company Summary
Table 59. Cyclacel Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Product Offerings
Table 60. Cyclacel Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Cyclacel Pharmaceuticals, Inc. Key News & Latest Developments
Table 62. ElexoPharm GmbH Company Summary
Table 63. ElexoPharm GmbH Pituitary ACTH Hypersecretion Drug Product Offerings
Table 64. ElexoPharm GmbH Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. ElexoPharm GmbH Key News & Latest Developments
Table 66. Ipsen S.A. Company Summary
Table 67. Ipsen S.A. Pituitary ACTH Hypersecretion Drug Product Offerings
Table 68. Ipsen S.A. Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Ipsen S.A. Key News & Latest Developments
Table 70. Isis Pharmaceuticals, Inc. Company Summary
Table 71. Isis Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Product Offerings
Table 72. Isis Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Isis Pharmaceuticals, Inc. Key News & Latest Developments
Table 74. Novartis AG Company Summary
Table 75. Novartis AG Pituitary ACTH Hypersecretion Drug Product Offerings
Table 76. Novartis AG Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Novartis AG Key News & Latest Developments
Table 78. Orphagen Pharmaceuticals, Inc. Company Summary
Table 79. Orphagen Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Product Offerings
Table 80. Orphagen Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Orphagen Pharmaceuticals, Inc. Key News & Latest Developments
Table 82. Pfizer Inc. Company Summary
Table 83. Pfizer Inc. Pituitary ACTH Hypersecretion Drug Product Offerings
Table 84. Pfizer Inc. Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Pfizer Inc. Key News & Latest Developments
Table 86. Pituitary ACTH Hypersecretion Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 87. Global Pituitary ACTH Hypersecretion Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Pituitary ACTH Hypersecretion Drug Production by Region, 2018-2023 (K Pcs)
Table 89. Global Pituitary ACTH Hypersecretion Drug Production by Region, 2024-2029 (K Pcs)
Table 90. Pituitary ACTH Hypersecretion Drug Market Opportunities & Trends in Global Market
Table 91. Pituitary ACTH Hypersecretion Drug Market Drivers in Global Market
Table 92. Pituitary ACTH Hypersecretion Drug Market Restraints in Global Market
Table 93. Pituitary ACTH Hypersecretion Drug Raw Materials
Table 94. Pituitary ACTH Hypersecretion Drug Raw Materials Suppliers in Global Market
Table 95. Typical Pituitary ACTH Hypersecretion Drug Downstream
Table 96. Pituitary ACTH Hypersecretion Drug Downstream Clients in Global Market
Table 97. Pituitary ACTH Hypersecretion Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pituitary ACTH Hypersecretion Drug Segment by Type in 2022
Figure 2. Pituitary ACTH Hypersecretion Drug Segment by Application in 2022
Figure 3. Global Pituitary ACTH Hypersecretion Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pituitary ACTH Hypersecretion Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pituitary ACTH Hypersecretion Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Pituitary ACTH Hypersecretion Drug Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Pituitary ACTH Hypersecretion Drug Revenue in 2022
Figure 9. By Type - Global Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Pituitary ACTH Hypersecretion Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Pituitary ACTH Hypersecretion Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Pituitary ACTH Hypersecretion Drug Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Pituitary ACTH Hypersecretion Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Pituitary ACTH Hypersecretion Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Pituitary ACTH Hypersecretion Drug Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Pituitary ACTH Hypersecretion Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Pituitary ACTH Hypersecretion Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Pituitary ACTH Hypersecretion Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Pituitary ACTH Hypersecretion Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Pituitary ACTH Hypersecretion Drug Sales Market Share, 2018-2029
Figure 23. US Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Pituitary ACTH Hypersecretion Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Pituitary ACTH Hypersecretion Drug Sales Market Share, 2018-2029
Figure 28. Germany Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Pituitary ACTH Hypersecretion Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Pituitary ACTH Hypersecretion Drug Sales Market Share, 2018-2029
Figure 37. China Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Pituitary ACTH Hypersecretion Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Pituitary ACTH Hypersecretion Drug Sales Market Share, 2018-2029
Figure 44. Brazil Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Pituitary ACTH Hypersecretion Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Pituitary ACTH Hypersecretion Drug Sales Market Share, 2018-2029
Figure 48. Turkey Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Pituitary ACTH Hypersecretion Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Pituitary ACTH Hypersecretion Drug Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Pituitary ACTH Hypersecretion Drug by Region, 2022 VS 2029
Figure 54. Pituitary ACTH Hypersecretion Drug Industry Value Chain
Figure 55. Marketing Channels

※参考情報

下垂体ACTH過剰分泌薬について説明いたします。まず、ACTH（副腎皮質刺激ホルモン）について理解することが重要です。ACTHは下垂体前葉から分泌され、副腎皮質を刺激してコルチゾールなどのステロイドホルモンの分泌を促進します。このホルモンの過剰分泌は、クッシング症候群やアジソン病といった内分泌系の病状に関与しているため、医学的には非常に重要なテーマです。

ACTHの過剰分泌は日常生活においても多様な症状を引き起こし、特にストレスに関連した反応の制御において大きな役割を果たします。ACTHの過剰分泌は通常、下垂体腫瘍、特にクッシング病によって引き起こされ、体内のホルモンバランスを大きく揺るがします。

ACTH過剰分泌の診断は、血中ACTH濃度や副腎からのコルチゾール分泌量の計測などによって行われます。これにより、ACTHの過剰分泌が確認された場合、治療が必要になります。

ACTH過剰分泌の治療は、通常、疾患の原因に応じて行われます。腫瘍が原因の場合、外科的な腫瘍切除が選択されることが一般的です。しかし、腫瘍が手術不能な場合や再発のリスクが高い場合には、薬物療法が考慮されます。ここにおいて、ACTH過剰分泌薬の役割が重要となります。

ACTH過剰分泌薬にはいくつかの種類があり、それぞれ異なるメカニズムで作用します。代表的なものとして、コルチコステロイドの合成を抑制する作用を持つ薬剤があります。これらの薬剤は、主に副腎におけるコルチゾールの合成を抑えて、体内のホルモンバランスを正常に戻すことを目的としています。また、ACTHの分泌を抑える薬剤も使用され、これにより下垂体腫瘍の成長を抑制する効果が期待されます。

具体的には、ビソプロロールやメトピロンなどがACTH過剰分泌の治療に用いられます。これらの薬剤は副作用が少なく、比較的安全に使用できるため、患者の生活の質を維持しながら治療を進めることが可能です。さらに、糖質コルチコイド受容体拮抗薬（RU-486など）も、治療の選択肢に含まれることがあります。

ACTH過剰分泌に対するアプローチは、薬物療法だけでなく、放射線療法や化学療法が併用されることもあります。特に腫瘍が原因の場合、放射線治療によって腫瘍の縮小を図ることが可能です。

最近の研究では、ACTH分泌の調節に関与する新たな分子標的治療の開発が進められています。たとえば、特定の遺伝子や分子を介して下垂体の機能を調整することで、より効果的な治療法の実現が期待されております。これにより、従来の治療法よりも副作用を抑えつつ、より高い治療効果を得ることが可能になるかもしれません。

また、研究が進むことで、ACTH過剰分泌状態における新たなバイオマーカーの発見も期待されています。これにより、診断の精度向上や、個々の患者に最適な治療法を選択するためのプロファイリングが可能になります。

下垂体ACTH過剰分泌の問題は、単なるホルモンの過剰分泌だけでなく、患者の生活全般に影響を与えるため、早期の診断と適切な治療が必要です。医療現場では、内分泌科、外科、放射線科などのチームが協力して、患者に対する総合的な治療が行われています。今後の研究により、より革新的な治療法が開発されることが期待され、それが患者の治療成績や生活の質を向上させることに寄与するでしょう。

以上のように、下垂体ACTH過剰分泌は多岐にわたる治療法が求められる複雑な疾患であり、治療においては医療チームの連携が不可欠です。新しい治療法の開発や今後の進展により、ACTH過剰分泌患者にとってより良い未来が切り開かれることが期待されています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 下垂体ACTH過剰分泌薬の世界市場見通し2023年-2029年(Pituitary ACTH Hypersecretion Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

下垂体ACTH過剰分泌薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp